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Removal of ecotoxicity of 
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17α -ethinylestradiol (EE2), a synthetic oestrogen in oral contraceptives, is one of many 
pharmaceuticals found in inland waterways worldwide as a result of human consumption and 
excretion into wastewater treatment systems. At low parts per trillion (ppt), EE2 induces feminisation 
of male fish, diminishing reproductive success and causing fish population collapse. Intended water 
quality standards for EE2 set a much needed global precedent. Ozone and activated carbon provide 
effective wastewater treatments, but their energy intensities and capital/operating costs are 
formidable barriers to adoption. Here we describe the technical and environmental performance of 
a fast- developing contender for mitigation of EE2 contamination of wastewater based upon small- 
molecule, full-functional peroxidase enzyme replicas called “TAML activators”. From neutral to basic 
pH, TAML activators with H2O2 efficiently degrade EE2 in pure lab water, municipal effluents and 
EE2-spiked synthetic urine. TAML/H2O2 treatment curtails estrogenicity in vitro and substantially 
diminishes fish feminization in vivo. Our results provide a starting point for a future process in which 
tens of thousands of tonnes of wastewater could be treated per kilogram of catalyst. We suggest 
TAML/H2O2 is a worthy candidate for exploration as an environmentally compatible, versatile, 
method for removing EE2 and other pharmaceuticals from municipal wastewaters.
Increasing evidence suggests that the presence of trace levels of pharmaceuticals in the environment 
can vitiate ecologies1. The most well researched effect involves the feminization of male fish exposed to 
effluents from wastewater treatment plants containing ethinylestradiol (EE2)2. EE2, a synthetic oestrogen 
in oral contraceptives, is found in inland waterways worldwide3 emanating from human excretion into 
wastewater treatment systems. At low parts per trillion (ppt), EE2 induces feminisation of wild male fish4, 
diminishing reproductive success5,6. Indeed in large-scale lake experiments in Canada7, 5–6 ppt EE2 led 
to the collapse of the lake’s population of fathead minnows, Pimephales promelas, and to longer term 
indirect effects on the lake foodweb8. Other examples of potential conflict between pharmaceutical use 
and ecological integrity include population collapse of Asian vultures contaminated by diclofenac9, and 
contamination of water and soil with antibiotics causing antimicrobial resistance10.
Within the EU, a combination of factors present a compelling case for mitigating pollution of rivers 
by EE2 and other pharmaceuticals11. These include: high human population density, increasing pharma-
ceutical consumption, intensifying animal husbandry, and limited water supplies. In practice, however, 
mitigation is hard to implement due to technical difficulties associated with monitoring these chemicals 
at low concentrations and the disproportionate cost of widespread installation of water treatment tech-
nologies able to remove them12,13.
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Although considered one of the biggest public health accomplishments of the 20th century, current 
wastewater treatment systems are not sustainable options for removing pharmaceuticals: Treatment by 
Activated Sludge Process (ASP) has proven to be inadequate at removing numerous pharmaceuticals 
creating the need for advanced treatment options. Ozone and activated carbon (AC) are the leading 
contenders for advanced treatment11 but their energy requirements, as well as capital and operating costs 
are formidable barriers to widespread adoption12, especially for smaller communities.
A technically effective, environmentally compatible and cost-effective way to overcome the impracti-
cality of using ozone or AC for removing pharmaceuticals from wastewater may come from treatment 
with hydrogen peroxide catalysed by extremely efficient TAML catalysts. Iron TAML activators (1, 2, 
Fig. 1) are full-functional, small molecule mimics of the peroxidase enzymes that at nanomolar concen-
trations (< 100 nM) can decompose many micropollutants. For example, in laboratory studies, TAML/
peroxide has been shown to efficiently degrade the persistent drug sertraline via its oxidative metab-
olites16, the recalcitrant pesticides trichlorophenol and pentachlorophenol17, thiophosphate pesticides 
such as fenitrothion18, dyes19,20 and many other micropollutants21. Preliminary studies on U.K municipal 
wastewater show that TAML/peroxide readily degrades numerous pharmaceuticals14.
The contraceptive pill hormone EE2 causes well-documented severe impacts on aquatic life15, there-
fore this study investigates the efficacy of TAML/peroxide at removing EE2 and it’s biological effects. 
Preliminary studies at high pH (8-10) and high concentrations of hydrogen peroxide (4 mM, 136 ppm) 
indicate that removal of EE2 and other estrogens (estradiol (E2), estrone (E1) all at 80 μ M) with TAML 
(83 nM 1) is possible22. In addition, in vivo toxicity tests using embryonic zebrafish suggest TAML is not 
overtly toxic to fish23 and in vitro tests also show TAML itself does not show inherent endocrine disrupt-
ing activity24. Taken together, these studies set the stage for the current multidisciplinary, cross-sector 
study to investigate the removal of EE2 from both laboratory waters and real wastewater, under more 
environmentally appropriate conditions. These include neutral pH, lower hydrogen peroxide concentra-
tions and estrogen concentrations of more than a million-fold lower than previously tested, which are 
much more environmentally relevant and still ecotoxic to fish.
Results
Degradation at various pH with TAML activators 1 and 2. Analogue 2 a more aggressive form of 
the parent TAML activator 1 (Fig. 2), are emphasized due to its superior performance over a pH range 
typically found in wastewaters. With this catalyst, degradation of EE2 (~10 ppm) with a fixed H2O2 
concentration (11.46 ppm) at pH 7.5 was completed within 25 min with 80 nM catalyst. The peroxide 
concentration was chosen in order to remain in excess of EE2. At this concentration, the peroxidase-like 
behaviour of TAML catalysts greatly outweighs any catalase-like behaviour25. The degradation time 
increased to 5 hours at 10 nM (5.4 ppb; Fig. 2). Taken together, the results show that 2 is about 10 times 
more effective than 1 at pH 7.5.
Determination of rate constant kII. The EE2 oxidation rate constant with 1 was experimentally 
determined to be 8.6 ± 0.5 × 105 M-1 s-1 (Supplementary information Fig. S2). With this information, the 
rate of degradation of EE2 in water at pH 7 could be reliably predicted (Supplementary information Eq. 
S1). At pH 7, the activation of the catalyst, described by rate constant kI, is usually the rate-determining 
step. However, at the extremely low concentrations of EE2 found in wastewater effluent and environ-
mental waters, the oxidation of EE2 by the active catalyst will be the rate-determining step as long as the 
concentration of hydrogen peroxide is greater than approximately 100 ppb (3 μ M). When compared to 
rate constants of other oxidants at pH 7, which have been measured by other researchers, the kII value is 
higher than ferrate, chlorite, hypochlorite, hypobromite and monochloramine, comparable to ozone and 
exceeded by hydroxyl radicals26,27.
Degradation of EE2 to isolate reaction intermediates. HPLC investigation of EE2 degradation 
with 1 or 2 and peroxide revealed the early formation and disappearance of two peaks with shorter 
retention times than EE2—the combined peak area attained a maximum as EE2 concentration reached 
Figure 1. TAML activators 1 and 2 used in this study; Y is typically water.
www.nature.com/scientificreports/
3Scientific RepoRts | 5:10511 | DOi: 10.1038/srep10511
its minimum, then declined rapidly and completely (Fig. 3; Top). UV spectra of the material in the new 
peaks are similar to the UV spectrum of EE2 suggesting early degradation intermediates. After isolation 
and purification via preparative HPLC, ESI-MS analysis revealed two masses common to the constituents 
of both HPLC peaks, 294 m/z (EE2–H2) and 312 m/z (EE2 + O)—a set of plausible structures based on 
known chemistry is shown in Fig.  3; Bottom. NMR studies of the two isolated fractions revealed that 
both consisted of mixtures of four compounds.
By comparing the 1H NMR spectrum of the intermediate mixture with the measured spectra of pur-
chased 3, 4 and 5 and the reported data for 7/8 (produced via a screening TAML/peroxide EE2 oxida-
tion)28, structural assignments were made. While ∆-9(11)-EE2 3 was present in the mixture, ∆-8(9)-EE2 
4 and ∆-6(7)-EE2 5 were not. Further analysis of the 1H and 13C and 2D NMR spectra (Supplementary 
information Figs. S4-S7) indicated a high probability that 8, 9 and 10 comprise the remaining members 
of the product mixture. A possible explanation for the HPLC and NMR data is that an initial oxidation 
intermediate forms which adds H2O under the catalytic conditions to give the multiple observed alco-
hol oxidation products. Compound 6 is primed for such water additions under catalytic conditions: an 
analogous product of electrochemical oxidation of E2 has been proposed29.
Determination of estrogenic activity of reaction intermediates in vitro via Yeast Estrogen 
Screen (YES) assay. The three possible intermediates available for purchase (3, 4 and 5) were tested 
in the Yeast Estrogen Screen (YES), a reporter gene assay which incorporates a recombinant human 
estrogen receptor30. All three compounds elicited estrogenic activity in vitro in the YES assay. In this 
assay 5 (∆-6(7)-EE2) was 57% as potent as EE2, 4 (∆-8(9)-EE2) was 52% as potent and 3 (∆-9(11)-EE2) 
was 35% as potent as EE2. As stated above, from the purchasable intermediates, only 3 was actually 
present in the intermediate mixture, and currently and 8, 9 and 10 cannot be bought and therefore tested 
for estrogenic activity.
Degradation of EE2 and removal of estrogenic activity in vitro - Yeast Estrogen Screen (YES) 
assays. To study the total degradation of EE2 via the intermediates at low, environmentally relevant 
concentrations, loss of estrogenicity with TAML/H2O2 treatment was measured using the YES assay 
(LOD = 0.1 ng.L-1 or ppt)30. Total estrogenicity (E2 equivalence; ppt EEQ) was completely removed by 
all treatments except the most mild ([1] = 80 nM and 0.16 ppm H2O2, unbuffered water, Supplementary 
information Fig. S1), indicating total destruction of all estrogenic intermediates in the higher H2O2 con-
centration experiments. These results emphasize the significant advantage of combining biological and 
chemical analysis as exhibited in this collaborative study. Mere destruction of the target compound, EE2, 
does not guarantee the removal of estrogenic activity or ecotoxicity.
Figure 2. Degradation of EE2 under a variety of environmentally relevant conditions. Graph: 
Degradation of EE2 at pH 7.5 (phosphate buffer, 0.01 M) with H2O2 (337 μ M, 11.46 ppm) catalysed by 2 
(10 nM, black circles), (25 nM, blue triangles), (34 nM, green squares), (80 nM, red diamonds) and catalysed 
by 1 (80 nM, yellow crosses). Inset: Concentration of EE2 with no catalyst and 50 equivalents of hydrogen 
peroxide. Conditions: [EE2] = 5× 10-5 M (14 ppm), [H2O2] = 2.5× 10-3 M (85 ppm), 0.01 M phosphate buffer at 
pH 6 (black circles), pH 7.5 (red squares), and pH 9 (blue triangles).
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Degradation of EE2 in synthetic urine under controlled pH conditions. TAML/peroxide is also 
efficacious in removing EE2 from spiked synthetic urine. At pH 10, 100 nM 1 was able to completely 
degrade EE2 (10 μ M) in synthetic urine with 60 mM H2O2 in 60 minutes. At pH 9, under the same con-
ditions there was approximately 30% degradation in the same time frame (results not shown).
Degradation of EE2 and removal of estrogenic activity in vivo – vitellogenin (VTG) induction 
in male fathead minnows.. We next examined the ability of 2/H2O2 to protect male fish from expo-
sures to pharmaceutical estrogen by exposing fathead minnows to EE2 (nominally 6.8 pM (2ppt)) plus 2/
H2O2 ([2] 80 nM, [H2O2] = 4.7 μ M (0.16 ppm)) treatment in continuous flow-through tanks. Treatment 
resulted in significantly lower (but still detectable) concentrations of EE2 in the EE2 + 2/H2O2 tanks 
(0.5 ± 0.32 ppt, mean ± standard error) compared with the EE2-only (5.87 ± 0.51 ppt) and EE2 + H2O2 
(4.85 ± 0.63 ppt) tanks (P = 0.004 and 0.006 respectively; ANOVA/LSD) (Fig. 4). This translates to 89.7% 
and 91.5% removal of EE2 in the EE2 + 2/H2O2 tanks compared to the EE2 + H2O2 and EE2-only tanks. 
For all treatments, there was strong agreement between the analytical chemistry and in vitro YES assay 
Figure 3. Typical degradation of EE2 with formation and subsequent degradation of intermediates. Top: 
Decay of EE2 (10 ppm) with H2O2 (337 μ M, 11.46 ppm) catalysed by 2 (80 nM, black) showing the combined 
formation and decay of three early degradation intermediates (red); pH 7.5 (phosphate buffer, 0.01 M). 
Bottom: Identified and likely EE2 degradation intermediates (also see Supplementary information).
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results (Fig. 4) indicating all possible estrogenic intermediates had also been destroyed. Significantly lower 
levels of the vitellogenin (VTG) biomarker were also observed in the exposed male fish (Fig. 4) in the 
EE2 + 2/H2O2 tanks compared to the EE2 + H2O2 and EE2-only tanks (P < 0.001 in both cases; ANOVA/
LSD). Due to this biomarker’s extreme sensitivity to exogenous estrogens, the 2/H2O2 + EE2 treatment 
fish still had elevated (although markedly reduced) VTG compared to the baseline (pre-exposure) and 
Control (no exposure) fish. The continuous flow-through set up and the low (non-toxic) concentration 
of H2O2 used in the in vivo study compared to the other experiments resulted in the very low residual 
concentration of EE2 in the EE2 + 2/H2O2 treatment. No significant effects on fish mortality of the func-
tioning 2/H2O2 in vivo treatment (3% (2 fish) over 21 day experiment) or condition factor (1.44 ± 0.02) 
were observed. In a wastewater treatment facility longer retention time and higher H2O2 concentrations 
could be tested to reduce EE2 even further.
Degradation of estrogens in Activated Sludge Process (ASP) effluent. Exploratory studies 
were performed to probe the efficacy of TAML/H2O2 (1, 40 nM) in removing EE2 from the effluent of 
a nitrifying activated sludge process (ASP) effluent at ambient temperature. In these limited laboratory 
studies, peroxide treatment in the presence of catalyst 1 was effective in reducing not only EE2, but 
also natural steroid estrogens, estrone (E1) and 17β -estradiol (E2). In general the removal of estrogens 
increased with increasing pH (pH 7, 8, 9), contact time (15, 30 and 45 min) and H2O2 concentration (10-
150 ppm) (Fig. 5). The oxidative degradation of steroid estrogens in wastewater samples using TAML/
H2O2 is dependent on a number of factors which include oxidant and catalyst dose, various water qual-
ity parameters such as organic and inorganic matter, dissolved and suspended solids as well as pH and 
temperature. At high pH, high removal of E1, E2 and EE2 occurs easily but at neutral pH or lower H2O2 
dose the effectiveness of TAML/H2O2 treatment is reduced for EE2 compared to E1 and E2, due to the 
higher chemical stability of EE2.
In general the duplicate samples taken in each of the four experiments gave comparable results. The 
total iron data showed that the increase in iron with addition of the catalyst is very small, increasing by 
only 5 and 10 μ g/l, a negligible amount from an environmental point of view.
Figure 4. Average EE2 concentration and estrogenic activity in treated and untreated waters with 
plasma vitellogenin in male fish exposed to the treatments for 21 days. EE2 concentration (ng/l, ppt; 
dark grey bar, 1st Y-axis) was measured by LC-MS/MS, estrogenic activity (EE2 equivalent ng/l, ppt; light 
grey bar, 1st Y-axis) was measured via in vitro Yeast Estrogen Screen (YES). Plasma vitellogenin (ng/
ml or ppb; grey cross X, 2nd Y-axis log scale) concentration in male fathead minnows were measured via 
a quantitative enzyme-linked immunosorbent assay (ELISA). EE2 chemical analysis results reported as 
< 0.03 ppt EE2 (i.e. lower than detection limit (LOD)) were treated as having half LOD (i.e. 0.015 ppt EE2) 
for use in calculations of averages, standard error and statistical analysis. EE2 and estrogenic activity are 
average measured concentrations sampled over the 21 day exposure. Plasma VTG was measured prior to 
exposure (baseline) and after 21 days exposure. The treatment regime consisted of; Control (water only), 2/
H2O2 + EE2, H2O2 + EE2, and EE2-only. All error bars represent standard error of the mean in all cases.
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Energy consumption is a major contributor to the operating cost of wastewater treatment plants and 
therefore an important parameter for choosing a treatment technology. As an example, ozone dose and 
therefore the energy consumption of ozonation is dependent on the characteristics of the wastewater to 
be treated and the type of chemical substances to be removed. A recent study on the energy consump-
tion of ozone to treat estrogenic substances31 showed that between 0.14-0.90 kWh/m3 was required for 
the removal of a range of estrogenic compounds from water. For EE2 specifically, the energy required 
was 0.2 kWh/m3. Based on electricity costs of €0.16 kWh-1, it is estimated the cost of ozone treatment 
of EE2 would be 0.032 € m3 and with the inclusion of capital investment and other costs, ozone will 
typically have costs of €0.18 m3. Comparing this with the TAML/H2O2 process and assuming the cost of 
energy in the production of H2O2 is 10.81 kWh per Kg of H2O232 then an application of 20 ppm would 
consume 0.216 kWh/m3 which is similar to 0.2 kWh of energy needed with ozone. A lower peroxide 
usage of 10 ppm would halve the energy consumption of the TAML process in comparison with ozone 
for EE2 removal, and would therefore be a cost and energy effective treatment. Therefore, cost and energy 
considerations favour a peroxide concentration of 10 ppm or lower. Process optimization is planned for 
pilot plant trials.
Conclusion
Taken together, the studies presented here clearly illustrate that Fe-TAML catalysts are extremely effective 
in the removal of steroid estrogens in wastewater in ways that are likely to dramatically reduce the fem-
inising effects of estrogenic sewage effluent discharges on wild fish in receiving waters. The application 
of Fe-TAML catalysts within wastewater treatment works is likely to represent a simple and effective 
environmentally sustainable alternative to current high technology advanced treatment processes.
Materials and Methods
Chemicals. All solvents were HPLC-grade unless otherwise stated. Analytical-grade EE2 and catalase 
(from Aspergillus niger, 2350 U mg-1) were obtained from Sigma-Aldrich. Hydrogen peroxide (30% w/w) 
was purchased from Fluka. The –H2 EE2 derivatives 3, 4 and 5 were purchased from Dalton Pharma 
Services (Toronto, ON). All other reagents and solvents (at least ACS reagent grade) were obtained from 
commercial sources (Aldrich, Fisher, Acros, and Fluka). TAML activator FeB* (1) was synthesized follow-
ing the published method22 and FeNO2BF2 (2) was obtained from GreenOx Catalysts (Pittsburgh, PA). 
Hydrogen peroxide stock solutions were standardized daily spectrophotometrically (ε = 72.4 M-1 cm-1)23. 
Phosphate buffer (0.1 M, potassium phosphate) was used as the reaction medium. The pH of each 
reaction mixture was adjusted by addition of potassium hydroxide or phosphoric acid solutions. Stock 
solutions of EE2 were prepared in methanol or ethanol (no effect from the alcohol was observed in 
the degradation pathway or rate) and were stored under refrigeration. Stock solution of 1 and 2 were 
prepared in methanol and were stored under refrigeration. Stock solutions of catalase (~23,500 U mL-1), 
used to quench the reactions by decomposing excess H2O2, were prepared in water and stored under 
refrigeration for a maximum of one week before disposal.
Figure 5. Effect of hydrogen peroxide concentration, pH and contact time on removal of steroid 
estrogens from sewage effluent using 1/H2O2. Conditions: [1] = 40 nM, room temperature, for pH 8, 9 and 
10 reactions sodium hydroxide was added to the effluent to achieve desired pH.
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Instrumentation and Analysis. A Shimadzu HPLC system [Shimadzu CMB-20A controller, 
LC-20AB pump, DGU-20A3 degasser, SPD-M20A diode array detector, RF-20A XS fluorimeter detector, 
CTO-20A column oven, and SIL-20A HT auto sampler] was used for monitoring the oxidative degrada-
tion of EE2. Chromatographic separation of EE2 and its degradation intermediates was achieved using 
an Agilent Microsorb-MV 100-5 C18 (250 mm x 4.6 mm, 5 μ m) column. HPLC analysis conditions were: 
25-uL injection volume, 40 °C column temperature, and isocratic elution using 40% acetonitrile and 60% 
water at 1-mL min-1 flow rate. The HPLC diode array detector was set to a 200–450 nm range and the 
fluorimeter detector was set to λ ex = 220 and λ em = 305 nm. The retention times of EE2 and its estrogenic 
degradation intermediates under these conditions were, respectively, 5.2, 3.0, and 3.4 minutes. ESI-MS 
analyses were performed using a Finnigan LCQ MS ion trap with ESI detection. A Bruker 500 MHz 
NMR instrument was used for 1H and 13C NMR studies (1D and 2D) at 300 K. The pH measurements 
were acquired with a Corning 220 pH meter calibrated with standard buffer solutions at pHs 4, 7, and 10.
Degradation Comparison at varying pH. A volume of EE2 stock solution was added to an aqueous 
solution of phosphate buffer (0.01 M) at the desired pH (pH 6.0, 7.5 and 9.0) and was sonicated at 40 °C 
for 20 minutes to ensure a homogenous solution, then cooled to room temperature. To this solution, a 
volume of catalyst stock (1 or 2) solution was added to achieve the 80 nM. An aliquot of the reaction 
mixture was analyzed by HPLC to measure the initial concentration. To the remaining mixture, a volume 
of H2O2 was added to initiate the reaction. The concentration of EE2 was monitored by HPLC various 
time intervals (e.g. pH 7.5 - Fig. 2), either by direct injection of the reaction mixture into the instrument 
(1, pH 6 and 7.5), or by quenching 1 mL aliquots with a small volume of catalase solution in an HPLC 
vial. The concentrations of each component in the reaction mixture are as follows: [EE2] = 33.7 μ M 
(10.00 ppm), [1] = 80.0 nM (0.04 ppm), [H2O2] = 337.4 μ M (11.48 ppm).
Determination of kII at pH 7. kII was determined by measuring the initial rate of degradation of 
EE2 at varying concentrations of EE2. The data was then plotted in a modified Lineweaver-Burke plot 
to linearize the data, with the slope of the line being equal to 1/kII (Supplementary information Fig. S2). 
The value of kII determined in this was 8.6 ± 0.5 × 105 M-1 s-1. To verify this value, EE2 was subjected to 
catalyzed degradation under conditions in which kII would be rate-limiting. This resulted in an exponen-
tial decay which was linearized by plotting ln(a0/at) vs. time (Supplementary information Fig. S3). The 
slope of the line was equal to kII[Fe]. This resulted in a rate 9.4 ± 0.2 × 105 M-1 s-1, which is within error 
of the previously calculated value.
Degradation of EE2 to isolate reaction intermediates. An appropriate volume of EE2 stock solu-
tion was added to a 1L aqueous solution of pH 9.0 phosphate buffer (0.01 M) and was first sonicated at 
40 °C for 20 minutes to ensure a homogenous solution, then was cooled to room temperature. To this 
solution, an appropriate volume of 1 stock solution was added. Degradation was then initiated by addition 
of an appropriate volume of H2O2 stock solution. At the experimentally determined time of maximum 
intermediate concentration, 1 mL of catalase was added to quench the remaining H2O2 in the reaction 
mixture. The concentrations of each component in the reaction mixture are as follows: [EE2] = 33.7 μ M 
(10.00 ppm), [1] = 80.0 nM (0.04 ppm), [H2O2] = 337.4 μ M (11.48 ppm). Sample was concentrated using 
solid phase extraction (Phenomenex Strata-X, 12 mL Gigatubes with 1g sorbent). SPE cartridges were 
eluted with acetonitrile and concentrated to 500 μ L for purification with preparative HPLC.
Determination of estrogenic activity of reaction intermediates in vitro via Yeast Estrogen 
Screen (YES) assay. EE2 reaction intermediates 3 (10.03 ppm), 4 (9.70 ppm) and 5 (9.74 ppm) 
(Dalton Pharma Services) and EE2 (10.00 ppm) were prepared as stock solutions in ethanol and assessed 
for estrogenic activity in the YES assay30. The other intermediate compounds were not tested by YES 
assay due to the inability to purchase them as standards.
Degradation of EE2 and removal of estrogenic activity in vitro - Yeast Estrogen Screen (YES) 
assay. Experiments were conducted to determine if estrogenic activity (of the parent and intermediate 
compounds) had been completely removed after treatment or if activity still persisted. These experiments 
were also designed to inform the subsequent in vivo experiment which would need to use much lower 
(more environmentally relevant) concentration of EE2 and non-toxic concentrations of H2O2. Twelve 
reactions were conducted using three concentrations of H2O2 at either unbuffered or fixed 7.5 pH. An 
appropriate volume of EE2 stock solution was added to a aqueous solution (500 mL or 1000 mL) of either 
unbuffered water or pH 7.5 phosphate buffer (0.01 M) to give a concentration of 6.75 pM (2 ppt) EE2. To 
this solution, an appropriate volume of either 1 or 2 stock solution was added to achieve a concentration 
of 80 nM. Degradation was then initiated by addition of an appropriate volume of H2O2 stock solution 
to give final concentrations of; 4.7, 47 or 470 μ M (0.16, 1.6, 16 ppm). After 45 minutes, the reaction was 
quenched with catalase. In addition to the twelve reactions two ‘positive controls’ - 2 ppt EE2 spiked into 
pH 7.5 or unbuffered solutions, and a ‘negative control’ – double distilled water only, were also prepared 
(i.e. without the addition of 1, 2 or H2O2). Each final solution was then concentrated with solid phase 
extraction (SPE) (Sep-Pak C18, Waters), and reconstituted in ethanol (0.5 mL or 1 mL to provide a 1000 
fold concentration). Concentrated extracts were then assayed for estrogenic activity in a sensitive in 
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vitro yeast estrogen screen (YES)30 a reporter gene assay incorporating a recombinant human estrogen 
receptor (LOD = 0.1 ng.L-1 or ppt).
Degradation of EE2 in synthetic urine under controlled pH conditions. Materials. pH 7.4 synthetic 
urine was obtained from CST Technology, EE2 was obtained from Sigma Aldrich, sodium carbonate and 
hydrogen peroxide were obtained from Fisher, catalysts 1 and 2 were obtained as previously mentioned.
Method. Sample matrix was prepared by adding saturated sodium carbonate to synthetic urine until 
pH 8, 9 or 10 was achieved. EE2, catalyst, and hydrogen peroxide were added to give concentrations 
of 1-10 μ M, 0.1-1 μ M, and 0.6-6 mM respectively. EE2 concentrations were measured by a Waters 600E 
HPLC, 2996 PDA detector and 717 autosampler. Separation was performed on a Waters X-Terra RP8 
150 × 4.6 column with gradient elution at the flow rate 1 mL/min. HPLC mobile phases includes MeCN 
and H2O. The injection volume was set at 20 μ L. Wavelength 280 nm was selected to record the chro-
matogram.
Degradation of EE2 and removal of associated biological effects in vivo – as measured by 
vitellogenin induction in male Fathead Minnows. The in vivo experiment was conducted to 
determine if EE2, and its associated biological effects could be significantly reduced by treatment under 
continuous flow-through conditions (as might be encountered at a wastewater treatment works). The 
fish used in this experiment are very sensitive to exogenous estrogens so a low but still ecotoxic EE2 
concentration was used as well as a low (non-toxic) concentration of H2O2.
Test organism. Fathead minnows for the in vivo study were bred and reared at Brunel University’s U.K. 
Home Office licensed aquatic facility. Adult male fathead minnows (18 months old) were maintained in 
the tanks at 25 °C ± 1 °C with a photoperiod of 16:8 h light:dark. Fish were fed frozen brine shrimp twice 
a day and flake food once a day.
Experimental design. For the in vivo assay the four treatments were 1) negative control (no chemicals 
added), 2) positive control (EE2 only), 3) hydrogen peroxide treated EE2 (H2O2 and EE2) and 4) 2/H2O2 
treated EE2 (2, H2O2 and EE2) (Supplementary information Fig. S8). Each treatment regime consisted 
of two replicate tanks each with 8 male fathead minnows. Each chemical stock (EE2, H2O2 and 2) was 
prepared and dosed separately so that the reaction only occurred in the mixing vessels (Supplementary 
information Fig. S8) prior to entering the fish tanks. Nominal concentrations (without reaction) in the 
mixing vessels were 2 ppt EE2, 80 nM 2, 0.16 ppm H2O2. Water in the mixing vessels were continuously 
stirred by magnetic stirrer, retention/mixing time within the vessel were approximately 45 minutes before 
entering the fish tanks.
Fish (mean wet weight 3.9 ± 0.3 g) were placed into their tanks 1 week prior to chemical exposure 
to acclimatize. An additional 5 male fish were also included at this time to be sampled before chemical 
addition to provide baseline VTG data on day 0 of the assay. Dissolved oxygen (6.52 ± 0.4 mg/l), pH 
(8.33 ± 0.1) and water temperature (25.5 ± 0.2 °C) were recorded daily, as was the functioning of the 
dilution and dosing system. On days 6, 13 and 20 water samples were collected from the exposure tanks 
for estrogenic (EE2 and estrogenic activity) analysis. Water samples were collected in large 5 L silanized 
glass beakers and treated with catalase (Sigma-Aldrich) final concentration 0.2 ppm to prevent further 
catalyst reaction. Water samples were split between LC-MS/MS EE2 analysis and YES analysis30. Samples 
for YES were immediately concentrated with SPE (Sep-Pak C18, Waters) and reconstituted in ethanol for 
analysis. Samples for LC-MS/MS were fixed with an acidified copper nitrate (HCl/Cu(NO3)2) to prevent 
biological degradation. Analysis was conducted by LC-MS/MS with a limit of detection of 0.03 ppt. 
Technical replicates, blanks and EE2 spiked samples were also analysed (LC-MS/MS and YES).
On days 0 and 21 fish were sampled for plasma VTG. Fish were terminally anaesthetized with buff-
ered MS-222 (Sigma-Aldrich) as approved by the U.K. Home Office (Animals (Scientific Procedures) Act 
1986). Blood was collected using a heparinized hemocrit tube, the blood was centrifuged at 7,000 g for 
5 min at 4 °C and the plasma collected and stored at -80 °C until analysis. Fish fork length and wet weight 
were recorded for each fish; condition factor was calculated as; (fish weight/fork length3) x100. Plasma 
VTG concentrations were measured via a quantitative enzyme-linked immunosorbent assay (ELISA) 
VGT kit designed specifically for fathead minnows (Biosense Laboratories, Norway). Plasma samples 
were diluted 1:50, 1:5,000, and 1:500,000 and assayed in duplicate according to the manufactures pro-
tocol.
Statistical analysis. Data (fish metrics and EE2 concentrations) were tested for homogeneity of variance. 
Parametric data was further analyzed using oneway ANOVA (followed by Least significant difference 
(LSD) post hoc analysis). Non parametric data was analyzed using Kruskal-Wallis Test (followed by 
Mann-Whitney U test post hoc analysis). EE2 chemical analysis results reported as < 0.03 ppt EE2 (i.e. 
lower than detection limit (LOD)) were treated as having half LOD (i.e. 0.015 ppt EE2) for use in calcu-
lations of averages, standard error and statistical analysis. Data on biomarker responses were compared 
using oneway ANOVA followed by Tukey’s post hoc test (VTG data were log10 transformed prior to 
analysis). For EE2 and VTG concentrations independent T-tests were also used to assess if any significant 
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differences occurred between tanks of the same treatment regime (tank effects). Statistical analysis was 
conducted using SPSS version 18. Differences were considered significant at p ≤ 0.05.
Degradation of estrogens in Activated Sludge Process (ASP) effluent. The wastewater effluent 
experiments were conducted to assess the efficacy of treatment to remove steroid estrogens under a num-
ber of reaction conditions including; varying pH (7-10), H2O2 concentration (10-150 ppm) and retention 
time (15-45 mins). These parameters and their possible cost implications are important if TAML/H2O2 
treatment is to be considered as an effective wastewater treatment technology.
ASP Effluent Study. Effluent was received from activated sludge sewage treatment plants in the UK. 
Samples were divided into containers of 2.5 litre volume and stored at room temperature. For samples 
at higher pH, the pH was adjusted with sodium hydroxide. Catalyst 1 and H2O2 (10, 20, 50, 100 or 
150 ppm) were added to each sample and allowed to react for the designated amount of time (15, 30 or 
45 mins). The reaction was quenched by addition of a reducing agent (ascorbic acid) to stop the oxidation 
reaction after a pre-determined time. An aliquot (2.5 litre) of the post reaction sample was transferred 
to a glass container, which was preserved with 3% v/v hydrochloric acid and 0.25% copper (II) nitrate. 
Samples were extracted using styrene-divinylbenzene solid phase extraction (SPE) cartridges and cleaned 
up using aminopropyl solid phase cartridges followed by gel permeation chromatography and analysed 
using LC-MS/MS to determine the percent removal of the estrogens studied.
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